Wieacker P, Alexopoulos A, DeGregorio G, Breckwoldt M
Universitäts-Frauenklinik, Medizinischen Universitätsklinik Freiburg.
Dtsch Med Wochenschr. 1989 Jul 14;114(28-29):1117-20. doi: 10.1055/s-2008-1066728.
A 29-year-old woman with Addison's disease was hospitalized in the eighth week of pregnancy because of an Addisonian crisis. The crisis was successfully treated with physiological saline infusions, as well as hydrocortisone (25 mg/d) and fludrocortisone (0.05 mg/d). The dose of fludrocortisone had to be increased to 0.1 mg/d from the 21st week of pregnancy onwards, because hyponatraemia and hypotension had once again developed. The hydrocortisone dose was raised to 37 mg/d from the 32nd week of pregnancy onwards because of a latent hypoglycaemia and raised further to 50 mg/d from the 35th week onwards because the retardation in fetal growth had become more marked. A mature infant was delivered spontaneously on the 282d day of pregnancy. At the start of labour the patient had been given 100 mg hydrocortisone intravenously and then 50 mg at the moment of delivery. The substitution treatment was gradually reduced to the original (pre-pregnancy) dosage during the first three post-partum days.
一名患有艾迪生病的29岁女性在怀孕第8周因艾迪生危象住院。通过输注生理盐水以及使用氢化可的松(25毫克/天)和氟氢可的松(0.05毫克/天)成功治疗了危象。从怀孕第21周起,由于再次出现低钠血症和低血压,氟氢可的松的剂量不得不增加至0.1毫克/天。从怀孕第32周起,由于存在潜在低血糖,氢化可的松剂量增至37毫克/天,从第35周起进一步增至50毫克/天,因为胎儿生长迟缓变得更加明显。在怀孕第282天自然分娩出一名成熟婴儿。分娩开始时,患者静脉注射了100毫克氢化可的松,然后在分娩时注射了50毫克。产后头三天,替代治疗逐渐减至原来(孕前)的剂量。